FDA Clears Augmenix’s SpaceOAR for Prostate Cancer Patients
News
The U.S. Food and Drug Administration (FDA) has cleared the first spacer for the U.S. market designed to protect the rectum of prostate cancer patients while receiving radiotherapy. The medical device is called ... Read more